Bottom line
MDCEX vs RMFGX: the short answer
MDCEX (Matisse Discounted Closed-End Fund Strategy) and RMFGX (American Mutual Fund) are both mutual funds.
But RMFGX is far broader, holding 146 positions to 30 for MDCEX, so beyond the top names it adds exposure MDCEX doesn't have.
RMFGX is cheaper at 0.27% vs 3.2% — a difference of $293 a year per $10,000 invested.
Over five years, MDCEX returned +16.0% a year vs +9.8% for RMFGX (reporting dates differ).
Updated Nov 19, 2026
MDCEX vs RMFGX side by side
| MDCEX | RMFGX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Starboard | American Funds (Capital Group) |
| Category | Large Blend | Large Blend |
| Expense ratio | 3.2% | 0.27% |
| Annual cost per $10k | $320 | $27 |
| 10-yr cost on $10k (prospectus) | $3,503 | $343 |
| Max front load | 0% | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +28.0% | +15.3% |
| 5-yr return (annualized) | +16.0% | +9.8% |
| 10-yr return (annualized) | +12.2% | +9.7% |
| Best quarter | +19.9% | +13.0% |
| Worst quarter | −37.1% | −18.2% |
| Net assets (fund) | $75.0M | $117.9B |
| Number of holdings | 30 | 146 |
| Portfolio turnover | 31% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
MDCEX and RMFGX share none of their top holdings.
MDCEX top 10
- Fidelity Investments — 7.26%
- Tetragon Financial — 6.56%
- NexPoint Diversified — 6.22%
- Taiwan Fund Inc/The — 5.99%
- The Korea Fund — 5.00%
- Pershing Square Hold — 4.06%
- The FS Credit — 3.73%
- Highland Income Fund — 3.61%
- SRH Total Return — 3.58%
- Royce Global Value — 3.57%
RMFGX top 10
- Microsoft Corp — 5.20%
- Broadcom Inc — 4.22%
- Philip Morris International Inc — 3.24%
- Eli Lilly And Co — 3.19%
- Cisco Systems Inc — 2.83%
- Apple Inc — 2.68%
- Starbucks Corp — 2.58%
- Abbvie Inc — 2.37%
- Capital Group Central Cash Fund — 2.24%
- Jpmorgan Chase & Co — 2.22%
FAQ
What is the difference between MDCEX and RMFGX?
Which is cheaper, MDCEX or RMFGX?
Should I own both MDCEX and RMFGX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.